Rankings · Quality
Longest A-grade streaks
Graded A at every quarter end of the run and still A today, longest run first. Counted from our point-in-time history, which uses only the filings that were public at each date.
15 companies meet this test
Figures as of November 15, 2026
| # | Company | Grade | Run at A | Revenue growth | Market value |
|---|---|---|---|---|---|
| 1 | VEEVVeeva Systems Inc. | A+ | 15 quarters | — | $48.8B |
| 2 | NVSNovartis AG | A | 10 quarters | +9% a year | $306.3B |
| 3 | ENSGENSIGN GROUP, INC | A | 10 quarters | — | $11B |
| 4 | KRYSKrystal Biotech, Inc. | A+ | 8 quarters | — | $9B |
| 5 | ALCAlcon Inc. | A | 7 quarters | +5% a year | $36.1B |
| 6 | ATRCAtriCure, Inc. | A | 7 quarters | +16% a year | $2.9B |
| 7 | BTSGBrightSpring Health Services, Inc. | A | 6 quarters | +26% a year | $14.2B |
| 8 | PENPenumbra, Inc | A | 6 quarters | +16% a year | $12.6B |
| 9 | INNVInnovAge Holding Corp. | A | 6 quarters | +13% a year | $1.3B |
| 10 | THCTENET HEALTHCARE CORP | A+ | 5 quarters | +3% a year | $22.8B |
| 11 | LLYELI LILLY AND COMPANY | A+ | 4 quarters | +39% a year | $1.36T |
| 12 | MDTMedtronic plc | A+ | 4 quarters | +6% a year | $131.6B |
| 13 | IDXXIDEXX LABORATORIES INC /DE | A+ | 4 quarters | +9% a year | $55.5B |
| 14 | NBIXNEUROCRINE BIOSCIENCES, INC. | A+ | 4 quarters | +28% a year | $16.9B |
| 15 | LFSTLifeStance Health Group, Inc. | A | 4 quarters | +19% a year | $5.4B |
More rankings
A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.